laboratory discovery; no human efficacy evidence

EVYR

Glutamic acid–valine–tyrosine–arginine

Metabolic

EVYR was identified and quantified after simulated dulse digestion and inhibited DPP-4 in a laboratory assay. Here is what that result shows—and what remains untested in humans.

Research status: laboratory discovery; no human efficacy evidence

Deep Dives on EVYR

Start here for the plain-English articles connected to this peptide.

Evidence Interpretation11 min read

Can a Seaweed Peptide Lower Blood Sugar? What the EVYR DPP-4 Study Actually Shows

EVYR was identified and quantified after simulated dulse digestion and inhibited DPP-4 in a laboratory assay. Here is what that result shows—and what remains untested in humans.

Read article

Quick Facts

Origin: Tetrapeptide identified and quantified after simulated digestion of dulse in Kumagai et al., Food Bioscience (2026)
Category: Metabolic

Mechanisms

Discussed in relation to seaweed peptide blood sugar research
Evidence quality varies by claim and should be separated from consumer marketing
Clinical relevance, safety, and long-term effects may remain uncertain

Research Areas